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Comorbidity 
■ Comorbid – Occurrence of two medical 
disorders in the same individual at a 
frequency greater than chance 
 
■ Most noted Migraine Comorbidities 















– Panic Attacks 
– Bipolar Disorder 
– Obsessive Compulsive Disorder 
– Phobia Disorder 
Migraine Comorbidities 
■ Psychiatric      Odds Ratio 
– Depression    2.2-3.4 
– Anxiety     2.7 
– Panic Attacks    3-5.1 
– Bipolar Disorder    2.9-7.3 
– Obsessive Compulsive Disorder  




Major Depression increases risk of 
Migraines 
 





– Patent Foramen Ovale 
• 30-40% Migraine with Aura 
– Atrial Septal Aneurysm 
• 28.5% Migraine with Aura 
– Mitral Valve Prolapse 
– Hypotension 
– Hypercoagulable State 
Prevalence of PFO and Migraine 
(Literature) 
      Migraine     No Migraine 
Del Sette        41%  16% 
Anzola        48%  20% 
Schwerzmann    47%  17% 
Domitrz       54%  25% 
Migraines and PFO Closure 
■ Some small case series showed  
improvement with closure 
– Schwerzmann 2004 
• 54 %(M+)  – 62 % (M-) decrease 
– Post et al 2004  
• 50 % (M-) – 71 % (M+) decrease 
 
   M-   =  Migraine without Aura 
   M+  =  Migraine with Aura 
Migraine and Vascular 
■ Cardiovascular 
 
– Women’s Health Study 
• Migraine with Aura  
2X likely to have stroke / cardiovascular disease 
 
– Physicians Health Study (men) 
• Increased risk of MI 
• Increased risk of Cardiovascular Disease 
 
 
American Migraine Study 
■ Risk Stroke 
 
■ Migraine       1.54 
■ M with Aura  2.78 
■ M without Aura  0.97  
■ Cardiovasc 
 
■ Migraine  2.16 
■ M with Aura 2.86 
■ M without Aura 1.85 
Migraine and Vascular 
■ Endothelial Dysfunction 
– Elevated Prothrombin levels 
• Migraine with Aura 
 
– Elevated Von Willebrand Factor 
(Procoagulant promoting platelet adherence) 
 
– Hypercoagulable State 
Migraine Comorbidities 
■ Sleep Disorders 
– More lifetime sleep problems in Migraine 
patients 
• Inadequate sleep 
• Difficulty initiating sleep 
• Persistent nightmares 
 
• Case Series (3582 patients) 




– Irritable Bowel Syndrome 
– Gastritis 





– Vertigo     
– Motion Sickness 
– Essential Tremor 
– Stroke  
– Epilepsy 
– Autonomic Nervous System 
– Fibromyalgia 
– Restless Leg Syndrome 
Migraine Comorbidities 
■ Migraine – Associated Vertigo 
 
– Dizziness clinic 
• 38% had migraine diagnosis 
 
– Migraine clinic 
• 9% suffered vertigo 
 (0.5% suffer vertigo in control population) 
Migraine Comorbidities 
■ Migraine – Associated Vertigo 
– Difficult to associate as onset of Migraines precedes 
Vertigo by years… 
• Migraines – early 20’s 
• Vertigo – 30s – 40s 
 
– Population Studies 
• Approx. 5% report consistent migraine and vertigo 
• Up to 70% report some combined episodes 
• Up to 30 % vertigo without migraine 
Migraine Comorbidities 
Migrainous Vertigo Criteria 
■ Definite 
– Episodic Vestibular 
symptoms of at least 
moderate severity 
– IHS Migraine Diagnosis   
– At least 1 of the following 
migrainous symptoms 
during at least 2 vertigo 
attacks 




– Episodic Vestibular 
symptoms of at least 
moderate severity 
– At least 1 of the following 
• Migraines 
• Migraine like triggers for 
vertigo 
• Migraine symptoms 
during vertigo 
– Photophobia,Phonopho
bia, Visual aura 
Migraine Comorbidities 
Autonomic Symptoms 
• Orthostatic Intolerance 
– Migraine – 39.1%  Control – 5.6% 
 
• Syncopy 
– Migraine – 46%  Control – 31% 
 
• Postural Orthostatic Tachycardic Syndrome 
(POTS)  
Migraine Comorbidities 
■ Postural Orthostatic Tachycardia Syndrome 
– Heart rate increase >= 30 beats per minute with standing 
5 – 10 minutes 
– Symptoms occur with standing, resolve with lying 
• Leg Mottling with standing 
– Women 4-5X more common 
– Co-morbidities 
• IBS, joint hypermobility 
Migraine Comorbidities 
■ POTS and Migraines 
– Small Case Series 
• 1 in 5 migraines associated with POTS 
 
– Tilt Table induced symptoms in 16 minutes 
 
– Normal Work up  
• MRI, EEG 
Migraine Comorbidities 
■ Fibromyalgia 
– Prevalence – 2% in North America 
 
– Women affected 3 times more than men 
 
– Peak Age 
• 55 – 64 years old 
Migraine Comorbidities 
■ Prevalence of Migraine in Fibromyalgia 
Case Series; Clinical Rheum journal 2005 
– Headache occurred in up to 76% patients 
– Migraine was seen in 48% patients  
 
■ Prevalence of Fibromyalgia in Migraneurs 
Cephalgia 2006 
– 17% in episodic migraine 
– 35% in chronic migraine 




– Cymbalta approval for Fibromyalgia 
• Physical Exercise + Cymbalta = most effective 
• Physical Exercise = second   
• Cymbalta = significant 
 
Migraine Comorbidities 
■ Complex Regional Pain Syndrome 
– 3.6 times more likely to be migraine sufferers 
– 2 times more likely to suffer Chronic Daily 
headaches 
 
■ If history of migraines 
– Earlier onset of CRPS 
– Involves more limbs 
“Migralepsy” 
■ Migraine and Epilepsy 
– Multiple studies indicate comorbid disease 
• Prevalance of Seizures  
– Migraine sufferers – Up to 17%  
– Non Migraine – 0.5 - 0.8% 
 




■ IHS criteria 
– i) Migraine with aura 
– ii) Seizure with or within 1 hour after migraine 
with aura attack 
 
■ Hypothesis / Pathophysiology 
– Cortical suppression by aura 
– Occipital cortex of Migraineurs with lowered 
excitation threshold (resistance) 
Migraine Comorbidities 
■ Allergies 
– Asthma, Hay Fever, Chronic Allergic Rhinitis – 
seen more often 
 
■ IgG food allergy testing 
– Screen for food allergy 
– Check levels of IgG with foods 
– Avoid foods which result in increased IgG 
Women and Migraines 
■ Peak of migraine frequency during days -3 
and +2 of the start of menstrual flow. 
 
■ 60% of women  
• have an increase risk of migraines during the 
premenstrual phase of decreasing estrogen levels. 
Hypothesis 
■ Estrogen modulates inhibitory peptide function in the trigeminal 
nerve. 
– When estrogen levels fall, the downregulating effect on inflammatory 
genes is removed. 
 
■ Compensatory mechanisms cannot always be invoked quickly 
enough to avoid headache. 
  
■ Is not seen with low E2 states maintained for months or years 
– Is seen with fluctuating E2 levels and irregular bleeding 
 
Conclusion 
■ Comorbidities are common and well 
recognized 
■ Treatment of the comorbidities may help 
prevent… 
– Vertigo attacks triggering Migraines 
– Allergies 
■ Basis of choosing preventative therapy is to 
attempt to treat Comorbidities 
– Insomnia = Nortriptyline 
– Anxiety = Depakote or Cymbalta 
 
